Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
Clinical trial NCT01047683 · COMPLETED
Trial details
- NCT number
- NCT01047683
- Sponsor
- Amarin Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2010-10-01
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.